FDA orders troubled Baltimore J&J contractor to pause manufacturing

Federal regulators ordered the embattled Emergent BioSolutions plant in Baltimore to stop producing new Johnson & Johnson vaccine material pending a completed inspection, the company said Monday. In a regulatory filing with the Securities…